Bone Regeneration Drug BMP-7 Mitigates Ponatinib-Induced Cardiotoxicity via Inhibition of Pyroptosis and Modulation of TGF-β/SMAD Signaling Pathway. [PDF]
Rolando JM, Singla DK.
europepmc +1 more source
Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP. [PDF]
Parcon PA +14 more
europepmc +1 more source
Efficient Approaches to the Design of Six-Membered Polyazocyclic Compounds-Part 2: Nonaromatic Frameworks. [PDF]
Titova YY, Gyrgenova EA, Ivanov AV.
europepmc +1 more source
Rh(iii)-catalyzed oxidative C-H annulation of 6-arylpyridazin-3(2<i>H</i>)-ones: direct access to diarylpyridazino[6,1-<i>a</i>]isoquinolin-5-ium-3-olates. [PDF]
Ittamalla C +4 more
europepmc +1 more source
Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy. [PDF]
Gregro AR +24 more
europepmc +1 more source
Economic evaluation of ponatinib vs reference and generic imatinib in front-line management of philadelphia chromosome-positive acute lymphoblastic leukemia: A value dilemma. [PDF]
Amamoo RS +5 more
europepmc +1 more source
Enantioselective copper-catalysed defluorinative alkylation of polyfluoroarenes with alkenes and 1,3-dienes. [PDF]
Shi D +10 more
europepmc +1 more source
Dual Proteasome and Histone Deacetylase Inhibition Overcomes Tyrosine Kinase Inhibitor Resistance in Breakpoint Cluster Region: Abelson 1-Driven Leukaemia Cell Lines. [PDF]
Okabe S +4 more
europepmc +1 more source
Tepotinib for the Treatment of Lung Adenocarcinoma Harboring MET Y1003N Point Mutation: A Case Report. [PDF]
Umeda Y +4 more
europepmc +1 more source
Residue dynamics and dietary risks of diflufenican and flufenacet in wheat using field experiments and model simulations. [PDF]
Pang N +7 more
europepmc +1 more source

